Analysts: Teva Pharmaceutical Industries Ltd (TEVA.K)

TEVA.K on New York Consolidated

53.48USD
22 Aug 2014
Price Change (% chg)

$-0.13 (-0.25%)
Prev Close
$53.61
Open
$53.61
Day's High
$54.00
Day's Low
$53.35
Volume
1,331,973
Avg. Vol
4,079,315
52-wk High
$55.70
52-wk Low
$36.26

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 1.22 December 22 Aug 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 8 7 7 6
(2) OUTPERFORM 7 6 6 6
(3) HOLD 14 14 13 14
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.21 2.26 2.23 2.31

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 18 5,081.42 5,247.00 4,833.89 5,086.73
Quarter Ending Dec-14 18 5,278.07 5,510.47 5,126.00 5,197.13
Year Ending Dec-14 22 20,403.10 20,709.00 20,063.40 20,168.10
Year Ending Dec-15 22 20,253.90 21,600.00 19,239.00 20,503.00
Earnings (per share)
Quarter Ending Sep-14 21 1.22 1.30 1.01 1.33
Quarter Ending Dec-14 21 1.27 1.35 1.17 1.39
Year Ending Dec-14 22 4.94 5.08 4.65 5.26
Year Ending Dec-15 24 4.96 5.71 4.22 5.42
LT Growth Rate (%) 6 1.32 4.00 -1.00 5.42

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-14 5,095.31 5,045.00 50.31 0.99
Quarter Ending Mar-14 5,114.30 5,001.00 113.30 2.22
Quarter Ending Dec-13 5,188.66 5,430.00 241.34 4.65
Quarter Ending Sep-13 5,004.67 5,059.00 54.33 1.09
Quarter Ending Jun-13 4,943.40 4,924.00 19.40 0.39
Earnings (per share)
Quarter Ending Jun-14 1.22 1.23 0.01 0.61
Quarter Ending Mar-14 1.22 1.22 0.00 0.36
Quarter Ending Dec-13 1.40 1.42 0.02 1.14
Quarter Ending Sep-13 1.26 1.27 0.01 0.67
Quarter Ending Jun-13 1.20 1.20 0.00 0.08

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 5,081.42 5,081.42 5,036.02 4,978.51 5,086.73
Quarter Ending Dec-14 5,278.07 5,278.07 5,215.29 5,148.76 5,197.13
Year Ending Dec-14 20,403.10 20,403.10 20,334.70 20,210.70 20,168.10
Year Ending Dec-15 20,253.90 20,253.90 19,994.80 19,872.80 20,503.00
Earnings (per share)
Quarter Ending Sep-14 1.22 1.22 1.17 1.13 1.33
Quarter Ending Dec-14 1.27 1.27 1.23 1.19 1.39
Year Ending Dec-14 4.94 4.94 4.79 4.72 5.26
Year Ending Dec-15 4.96 4.96 4.86 4.83 5.42

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 9 4
Quarter Ending Dec-14 0 0 8 5
Year Ending Dec-14 0 0 9 8
Year Ending Dec-15 0 0 10 7
Earnings
Quarter Ending Sep-14 0 0 12 2
Quarter Ending Dec-14 0 0 12 3
Year Ending Dec-14 0 0 15 0
Year Ending Dec-15 0 0 15 2

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks